DaVita (NYSE:DVA) Reaches New 12-Month High at $142.29

DaVita Inc. (NYSE:DVAGet Free Report) reached a new 52-week high during trading on Thursday . The stock traded as high as $142.29 and last traded at $141.17, with a volume of 90917 shares trading hands. The stock had previously closed at $139.75.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. StockNews.com upgraded shares of DaVita from a “buy” rating to a “strong-buy” rating in a research note on Thursday, April 25th. UBS Group lifted their price target on shares of DaVita from $113.00 to $134.00 and gave the stock a “buy” rating in a research note on Wednesday, February 14th. Barclays assumed coverage on shares of DaVita in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $133.00 price target for the company. TheStreet upgraded shares of DaVita from a “c+” rating to a “b-” rating in a research note on Wednesday, February 7th. Finally, Truist Financial boosted their price objective on shares of DaVita from $130.00 to $135.00 and gave the stock a “hold” rating in a research report on Tuesday, February 20th. Two research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, DaVita has an average rating of “Moderate Buy” and an average price target of $118.50.

Check Out Our Latest Stock Report on DVA

DaVita Stock Up 1.3 %

The business’s fifty day moving average price is $133.13 and its 200 day moving average price is $111.96. The firm has a market capitalization of $12.41 billion, a price-to-earnings ratio of 18.89, a PEG ratio of 1.24 and a beta of 1.04. The company has a current ratio of 1.19, a quick ratio of 1.13 and a debt-to-equity ratio of 6.65.

DaVita (NYSE:DVAGet Free Report) last announced its quarterly earnings data on Tuesday, February 13th. The company reported $1.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.53 by $0.34. The company had revenue of $3.15 billion for the quarter, compared to analysts’ expectations of $3.01 billion. DaVita had a net margin of 5.70% and a return on equity of 64.42%. DaVita’s revenue was up 7.8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.11 EPS. On average, equities analysts expect that DaVita Inc. will post 9.23 EPS for the current year.

Insider Buying and Selling at DaVita

In other news, CEO Javier Rodriguez sold 67,603 shares of the company’s stock in a transaction on Monday, February 26th. The shares were sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the transaction, the chief executive officer now directly owns 488,697 shares of the company’s stock, valued at approximately $61,629,578.67. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, CEO Javier Rodriguez sold 67,603 shares of the business’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $126.11, for a total value of $8,525,414.33. Following the sale, the chief executive officer now directly owns 488,697 shares in the company, valued at approximately $61,629,578.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider James O. Hearty sold 26,164 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $119.64, for a total transaction of $3,130,260.96. Following the completion of the transaction, the insider now owns 20,264 shares in the company, valued at $2,424,384.96. The disclosure for this sale can be found here. In the last three months, insiders have sold 134,540 shares of company stock valued at $16,551,071. 1.40% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of DVA. First Trust Direct Indexing L.P. grew its position in DaVita by 3.9% in the first quarter. First Trust Direct Indexing L.P. now owns 2,590 shares of the company’s stock valued at $358,000 after acquiring an additional 98 shares in the last quarter. State of Michigan Retirement System grew its position in DaVita by 0.6% in the fourth quarter. State of Michigan Retirement System now owns 15,939 shares of the company’s stock valued at $1,670,000 after acquiring an additional 100 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of DaVita by 18.8% during the 1st quarter. GAMMA Investing LLC now owns 657 shares of the company’s stock valued at $91,000 after buying an additional 104 shares during the last quarter. Treasurer of the State of North Carolina boosted its stake in shares of DaVita by 0.5% during the 3rd quarter. Treasurer of the State of North Carolina now owns 24,503 shares of the company’s stock valued at $2,316,000 after buying an additional 123 shares during the last quarter. Finally, Daiwa Securities Group Inc. boosted its stake in shares of DaVita by 3.2% during the 3rd quarter. Daiwa Securities Group Inc. now owns 4,631 shares of the company’s stock valued at $438,000 after buying an additional 144 shares during the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

About DaVita

(Get Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Read More

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.